Exhibitors & Sponsors

The exhibition will take place in the Upper and Lower River Rooms and stands will be allocated on a first-come, first-served basis on arrival.

Please note: ALL stands are 2m x 2m and table top (no shell scheme will be provided).

For any exhibitor enquiries please contact Stephanie Tweedale: dasevents@aagbi.org or 020 7631 8817.

Download the DAS 2017 London Exhibition and Sponsorship pack here.

We welcome the following exhibitors to DAS 2017 London:

  • 3M UK PLC
  • Aeon Astron Europe B.V.
  • Ambu Ltd
  • Armstrong Medical
  • Distinctive Medical
  • Fannin UK Ltd
  • Fisher & Paykel Healthcare Ltd
  • Flexicare Medical Limited
  • Freelance Surgical Limited
  • Healthcare 21
  • Intersurgical
  • Karl Storz Endoscopy (UK) Ltd
  • Medical-Devices Ltd
  • MSD
  • Orsim
  • P3 Medical Ltd
  • Proact Medical Ltd
  • Teleflex
  • Tristel
  • Trucorp
  • Vyaire
  • Verathon
    Well Lead Medical Co. Ltd

We would also like to thank the following companies for sponsoring DAS 2017 London:

  • Ambu
  • Fannin / Airtraq
  • Fisher & Paykel Healthcare Ltd
  • Intersurgical
  • Karl Storz Endoscopy (UK) Ltd

INDUSTRY-SPONSORED SYMPOSIUM – sponsored by Fisher & Paykel Healthcare Ltd
Thursday 23 November, 12:15-13:00           Lunch will be provided.

“Evolution of Optiflow THRIVE – An update on potential applications”
Location: Auditorium
Drs Alistair McNarry (Edinburgh), Fauzia Mir (London) & Peter Groom (Liverpool)

Optiflow™ Nasal High Flow Therapy is a revolutionary respiratory support system which offers the ability to comfortably deliver a complete range of oxygen concentrations and flows to extend the traditional boundaries of oxygen therapy.
This is achieved through the integration of heated humidification and a precise blend of air and oxygen delivered via an innovative wide bore, soft, nasal cannula.
Clinical data suggests that Optiflow may lead to:
• More effective treatment and reduced escalation of care
• Increased patient and caregiver satisfaction
• Increased therapy compliance
Optiflow™ THRIVE is changing the way emergency and difficult intubations are managed – from a pressured start-stop process to a smooth and unhurried undertaking. Optiflow™ THRIVE increases apnoea time in patients undergoing general anaesthesia which makes securing a definitive airway a smooth and unpressured undertaking.
Optiflow™ Nasal High Flow Therapy and Optiflow™ THRIVE are now well established therapies, featuring in hundreds of publications and appearing in such prestigious journals as the NEJM and JAMA. The therapies are not confined to any one department within the hospital and new applications are being discovered all the time.



To view the programme please click here.

Read more…


The workshops are being held on Wednesday 22nd November, those booked onto the workshops will rotate around 8 stations throughout the day.

Read more…

Social Programme

This will include an opening drinks reception and gala dinner.

Read more…

Sorry, but your category is empty!